Uptake and Tolerability of Repeated Mucosal Specimen Collection in Two Phase 1 AIDS Preventive Vaccine Trials in Kenya

Retrovirology - United Kingdom
doi 10.1186/1742-4690-9-s2-p122
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tolerability and Acceptability of Electroporation During a Phase 1 Vaccine Trial at Two Sites in Uganda and Rwanda

Retrovirology
VirologyInfectious Diseases
2012English

Preventive Misconception and Adolescents’ Knowledge About HIV Vaccine Trials

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2013English

US Dispute Over Live AIDS Vaccine Trials

Nature
Multidisciplinary
1997English

Volunteer Motivators for Participating in HIV Vaccine Clinical Trials in Nairobi, Kenya

PLoS ONE
Multidisciplinary
2017English

Experiences in Recruiting Volunteers Through Community Based Initiatives in Phase-1 Vaccine Trials in India

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Molecular Characterization of HIV Type 1 Among HIV-Infected Respondents in a Cohort Being Prepared for HIV Phase III Vaccine Clinical Trials, Western Kenya

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2011English

Contraceptive Use in Women Enrolled Into Preventive HIV Vaccine Trials: Experience From a Phase I/Ii Trial in East Africa

PLoS ONE
Multidisciplinary
2009English

Sieve Analysis in HIV-1 Vaccine Efficacy Trials

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2013English

Are Young Injection Drug Users Ready and Willing to Participate in Preventive HCV Vaccine Trials?

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy